Meeting
2018 ASCO Annual Meeting
Impact of curcumin with and without (+/-) piperine on tamoxifen exposure.
Authors
Gerardus Hussaarts
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Gerardus Hussaarts , Daan Hurkmans , Esther Oomen De Hoop , Leonie J. van Harten , Stan Berghuis , Robbert J. van Alphen , Leontine E.A. Spierings , Quirine C. van Rossum , Mijntje B. Vastbinder , Ron H.N. van Schaik , Teun van Gelder , A. Jager , Roelof W.F. van Leeuwen , Ron H.J. Mathijssen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Pharmacology
Clinical Trial Registration Number
NTR6149
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2572)
DOI
10.1200/JCO.2018.36.15_suppl.2572
Abstract #
2572
Poster Bd #
398
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Simplified CYP2D6 metabolizer phenotype categorization of patients treated with tamoxifen: Role for endoxifen level monitoring?
First Author: Clara Inkyung Lee
Poster
2016 ASCO Annual Meeting
Comparison of endoxifen levels between male and female breast cancer patients treated with tamoxifen.
First Author: John Gordon Lenehan
Poster
2014 ASCO Annual Meeting
Does increasing the daily tamoxifen dose in patients with diminished CYP2D6 activity increase toxicity?
First Author: Daniel Louis Hertz
Poster
2014 ASCO Annual Meeting
Pharmacokinetic analysis of tamoxifen metabolites in premenopausal women with early breast cancer: A substudy of NCIC CTG MA.12 randomized clinical trial.
First Author: Shahbal Bill Kangarloo